Ardea Biosciences, Inc. (RDEA) Reports Q1 Loss of $1.25/Share

May 7, 2012 8:31 AM EDT Send to a Friend
Ardea Biosciences, Inc. (NASDAQ: RDEA) reported Q1 EPS of ($1.25), $0.27 worse than the analyst estimate of ($0.98). Revenue for the quarter came in at $1.5 million versus the consensus estimate of $3 million.

For earnings history and earnings-related data on Ardea Biosciences, Inc. (RDEA) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment